JUSTIN MERZLOCK: Open Payments
NPI 1013668847 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 31 payments from 12 companies in 2025. Trend: 2023 $322 · 2024 $481 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $159 |
| ANI Pharmaceuticals, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Calliditas Therapeutics US Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Vifor Pharma, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Fresenius USA Marketing, Inc. | 1 | $17 |
Products named: TAVNEOS, KRYSTEXXA, PURIFIED CORTROPHIN GEL, JYNARQUE, TARPEYO, BENLYSTA, ULTOMIRIS, Veltassa.
Industry payments across ID — which companies pay providers there.
